Sanofi India Share Price

₹ 3,381.60

+₹31.80 (0.95%)

Last updated 03 Nov, 2026, 15:54 IST

NSE: SANOFI

Sanofi India Share Price Today

As of 3 Nov 2026, Sanofi India share price is ₹3,381.60. The stock opened at ₹3,375.00, compared to its previous close of ₹3,349.80. During today's trading session, Sanofi India share price moved in the range of ₹3,351.90 to ₹3,396.00, with an average price of ₹3,373.95 for the day. Looking at its last 52-week, the stock has touched a low of ₹2,758.20 and a high of ₹4,832.00. On the performance front, Sanofi India share price has declined by 1.68% over the last six months and is down 29.93% on a year-on-year basis.

₹3,351.90

0.95% up today

₹3,396.00

1D LOW

1D HIGH

Sanofi India Stock Insights

Latest Earning

Op Profit TrendUp by 8.53% QoQ

Latest Earning

Net Profit TrendUp by 11.07% QoQ

Latest Earning

Revenue TrendDown by 1.05% QoQ

Stock Performance

OutperformingBeat Nifty by 2.9 % in last 1 month

Shareholding Pattern

DIIDII increased stake by 0.50%

Shareholding Pattern

FIIFII increased stake by 0.67%

Sanofi India Stock Insights

Latest Earning

Op Profit TrendUp by 8.53% QoQ

Latest Earning

Net Profit TrendUp by 11.07% QoQ

Latest Earning

Revenue TrendDown by 1.05% QoQ

Stock Performance

OutperformingBeat Nifty by 2.9 % in last 1 month

Shareholding Pattern

DIIDII increased stake by 0.50%

Shareholding Pattern

FIIFII increased stake by 0.67%

Sanofi India stock performance
Open	₹3,375.00
High	₹3,396.00
Low	₹3,351.90
Prev. close	₹3,349.80

Sanofi India trading activity
Volume	40,608
Average traded price	₹3,378.80
Last traded time	03:54:23 03 Nov
Last traded quantity	3

₹2,679.90₹4,019.70

Circuit Low

Circuit High

₹2,758.20₹4,832.00

52-Week Low

52-Week High

Circuit

₹2,679.90

₹4,019.70

52-week

₹2,758.20

₹4,832.00

Mkt Cap Cr

8,111.74

P/E

34.06

P/B

16.36

ROA

46.03%

ROE

47.13%

ROCE

47.95%

Quick Ratio

0.87

EV/EBITDA

24.25

Mkt Cap Cr

8,111.74

P/E

34.06

P/B

16.36

ROA

46.03%

ROE

47.13%

ROCE

47.95%

Quick Ratio

0.87

EV/EBITDA

24.25

Based on fundamentals, this stock's

Performance

Excellent

Sanofi India outperforming all market indices

Valuation

Overvalued

Sanofi India appears overvalued compared to its peers

Earnings

Neutral

Sanofi India earnings growth is positive

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROA	ROE	ROCE	Quick Ratio	EV/EBITDA
Sun Pharmaceutical Industries	4,24,202.42	38.61	4.75	9.61%	13.79%	18.65%	2.31	22.27
Divis Laboratories	2,57,902.73	90.31	15.76	14.6%	15.32%	19.56%	3.5	58.97
Torrent Pharmaceuticals	1,74,402.47	83.09	9.49	4.7%	11.42%	11.37%	0.75	33.6
Laurus Labs	1,26,811.28	95.17	20.92	11.58%	22.11%	20.91%	0.68	54.77
Zydus Lifesciences	1,24,089.48	26.93	4.56	8.57%	18.59%	17.35%	0.91	16.42
Dr. Reddy's Laboratories	1,11,868.03	40.54	2.88	4.79%	7.21%	8.58%	1.35	19.05
Cipla	1,11,647.72	39.12	3.15	6.6%	8.18%	10.8%	2.5	21.03
Mankind Pharma	1,02,195.62	45.15	5.81	7.82%	12.76%	14.68%	0.74	25.01
Aurobindo Pharma	96,951.18	26.13	2.56	6.34%	9.25%	11.76%	1.15	12.38
Lupin	91,870.16	16.45	4.07	14.47%	23.76%	24.88%	1.42	9.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Sanofi India Company Background

ISIN

INE058A01010

Sector Market Cap

₹ 8,111.74 Cr

Sanofi India Limited is an India-based company, which is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The Company produces pharmaceutical formulations, dosage forms and offer a range of medicines across various therapeutic areas. Its product portfolio is focused on five therapeutic areas: diabetes, epilepsy, cardiology, allergy and pain care. In the diabetes area, the Company has an insulin portfolio under the brand name of Lantus, which helps in controlling high blood sugar in adults and children with diabetes mellitus. It also provides Toustar pen, along with dedicated Toujeo cartridges, addressing the need for a reusable delivery device. Combiflam, its product, helps to reduce pain and inflammation in conditions like headache, muscle and joint pain, and also reduces fever. Its brands also include Cardace, Allegra, Avil and Frisium. The Company has its own manufacturing facility in Goa. It has around 12 contract manufacturing organizations.

Sanofi India Financial Highlights

Revenue: Sanofi India reported revenue of ₹2,029.70 crore in FY24 vs ₹2,057.30 crore in FY23. It showed a decrease of 1.34% on a yearly basis.
Operating Profit: Sanofi India reported an operating profit of ₹431.40 crore in FY24 vs ₹528.50 crore in FY23. It showed a decrease of 18.37% on a year-on-year basis.
Net Profit: Sanofi India reported a net profit of ₹413.30 crore in FY24 vs ₹602.90 crore in FY23. It showed a decrease of 31.45% on a yearly basis.

Sanofi India Quarterly Result Highlights

Sanofi India reported revenue of ₹520.80 crore in Dec 2024, compared with ₹526.30 crore in Sep 2024, representing a decrease of 1.05% on a quarter-on-quarter (QoQ) basis.
Sanofi India reported an operating profit of ₹122.20 crore in Dec 2024, compared with ₹112.60 crore in Sep 2024, representing an increase of 8.53% on a quarter-on-quarter (QoQ) basis.
Sanofi India reported a profit of ₹91.30 crore in Dec 2024, compared with ₹82.20 crore in Sep 2024, reflecting an increase of 11.07% on a QoQ basis.
The earnings per share (EPS) of Sanofi India stood at ₹179.46 during Dec 2024.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters

60.40%

FII

5.73%

Other DII

10.78%

Retail and other

14.47%

Mutual funds

8.62%

Foreign Institutional Investor (FII)

FII shareholding by period
Dec 2025	5.55%
Mar 2026	5.64%
Jun 2026	5.69%
Sep 2026	5.73%

Sanofi India Investment Returns

1 day

+4.55%

1 week

+17.42%

1 month

+10.29%

1 year

-29.93%

3 years

-55.93%

5 years

-59.20%

Sanofi India Share Price History

Sanofi India share price history by day, showing open and close prices and the percentage change
Day	Open / Close	Change %
02 Nov 26	₹3,250.00 / ₹3,349.80	+4.55%
30 Oct 26	₹3,265.00 / ₹3,204.10	+0.46%
29 Oct 26	₹3,010.00 / ₹3,189.50	+6.60%
28 Oct 26	₹3,080.00 / ₹2,992.00	-2.70%
27 Oct 26	₹2,830.00 / ₹3,075.00	+7.79%
26 Oct 26	₹2,773.80 / ₹2,852.80	+2.89%
23 Oct 26	₹2,838.10 / ₹2,772.80	-2.06%
22 Oct 26	₹2,830.00 / ₹2,831.10	+0.13%
21 Oct 26	₹2,898.90 / ₹2,827.30	-1.84%
19 Oct 26	₹2,940.00 / ₹2,880.30	-2.10%

Sanofi India Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
Particulars	Dec 2024	Dec 2023
Revenue	₹2,013.20	₹1,996.10
Other Income	₹16.50	₹61.20
Total Revenue	₹2,029.70	₹2,057.30
Total Expenses	₹1,560.60	₹1,546.60
Profit Before Tax	₹431.40	₹528.50
Tax	₹117.70	₹163.90
Profit After Tax	₹313.70	₹364.60
EPS - Basic	₹179.46	₹261.78
EPS - Diluted	₹179.46	₹261.78

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
Particulars	Dec 2024	Dec 2023
Profit before tax	₹562.40	₹845.50
Income before WC changes	₹587.50	₹820.70
Change in Assets	-₹186.60	-₹241.80
Change in Liabilities	₹158.00	-₹107.20
Change in WC	-₹28.60	-₹349.00
Cash flow from Operations	₹461.50	₹230.40
Cash flow from Investing	-₹19.20	₹37.50
Cash flow from Financing	-₹392.40	-₹878.30
Total Cash Flow	₹49.90	-₹610.40
Cash (Start of the year)	₹394.50	₹1,004.90
Cash (End of the year)	₹283.80	₹394.50

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
Particulars	Dec 2024	Dec 2023
Non-Current Assets	₹485.00	₹466.80
Current Assets	₹1,126.80	₹1,248.00
Total Assets	₹1,611.80	₹1,714.80
Current Liabilities	₹719.20	₹651.30
Net Current Asset	₹407.60	₹596.70
Non-Current Liabilities	₹32.00	₹48.30
Equity Capital	₹860.60	₹1,015.20
Total Equity & Liabilities	₹1,611.80	₹1,714.80

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Dec 2025	Dec 2024	Dec 2023	Dec 2022
Revenue	₹1,837.40	₹2,013.20	₹2,851.10	₹2,770.10
Other Income	₹19.70	₹16.50	₹65.30	₹71.50
Total Revenue	₹1,857.10	₹2,029.70	₹2,916.40	₹2,841.60
Total Expenses	₹1,385.10	₹1,560.60	₹2,088.40	₹2,109.30
Profit Before Tax	₹444.70	₹431.40	₹845.80	₹864.30
Tax	₹118.00	₹117.70	₹242.60	₹243.70
Profit After Tax	₹326.70	₹313.70	₹603.20	₹620.60
EPS - Basic	₹141.85	₹179.54	₹261.91	₹269.47
EPS - Diluted	₹141.85	₹179.54	₹261.91	₹269.47

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Dec 2025	Dec 2024	Dec 2023	Dec 2022
Profit before tax	₹444.70	₹562.60	₹845.80	₹864.30
Income before WC changes	₹473.50	₹587.70	₹821.00	₹705.00
Change in Assets	₹310.90	-₹186.60	-₹241.70	-₹16.50
Change in Liabilities	-₹239.30	₹158.00	-₹107.20	-₹29.10
Change in WC	₹71.60	-₹28.60	-₹348.90	-₹45.60
Cash flow from Operations	₹438.30	₹461.70	₹230.80	₹398.70
Cash flow from Investing	-₹11.30	-₹19.20	₹35.50	₹650.90
Cash flow from Financing	-₹447.90	-₹392.40	-₹878.30	-₹1,582.70
Total Cash Flow	-₹20.90	₹50.10	-₹612.00	-₹533.10
Cash (Start of the year)	₹283.80	₹392.90	₹1,004.90	₹1,538.00
Cash (End of the year)	₹262.90	₹283.80	₹392.90	₹1,004.90

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Dec 2025	Dec 2024	Dec 2023	Dec 2022
Non-Current Assets	₹454.20	₹485.00	₹468.80	₹461.40
Current Assets	₹800.60	₹1,126.80	₹1,246.30	₹1,610.30
Total Assets	₹1,254.80	₹1,611.80	₹1,715.10	₹2,071.70
Current Liabilities	₹491.40	₹736.50	₹651.30	₹740.60
Net Current Asset	₹309.20	₹390.30	₹595.00	₹869.70
Non-Current Liabilities	₹14.20	₹14.70	₹48.30	₹55.30
Equity Capital	₹749.20	₹860.60	₹1,015.50	₹1,275.80
Total Equity & Liabilities	₹1,254.80	₹1,611.80	₹1,715.10	₹2,071.70